OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
microRNA miR-133a as a Biomarker for Doxorubicin-Induced Cardiotoxicity in Women with Breast Cancer: A Signaling Pathway Investigation
Michelle Teodoro Alves, Izabela Mamede, Angélica Navarro de Oliveira, et al.
Cardiovascular Toxicology (2022) Vol. 22, Iss. 7, pp. 655-662
Closed Access | Times Cited: 7
Michelle Teodoro Alves, Izabela Mamede, Angélica Navarro de Oliveira, et al.
Cardiovascular Toxicology (2022) Vol. 22, Iss. 7, pp. 655-662
Closed Access | Times Cited: 7
Showing 7 citing articles:
Circulating MicroRNA as Biomarkers of Anthracycline-Induced Cardiotoxicity
Hanne M. Boen, Martina Cherubin, Constantijn Franssen, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 183-199
Open Access | Times Cited: 7
Hanne M. Boen, Martina Cherubin, Constantijn Franssen, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 183-199
Open Access | Times Cited: 7
MicroRNA‑96 promotes the proliferation and migration of breast cancer cells by inhibiting Smad7 expression
Xiu‐Mei Zhang, Cong Lin, Rong Yu, et al.
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access
Xiu‐Mei Zhang, Cong Lin, Rong Yu, et al.
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access
Early detection of anthracycline-induced cardiotoxicity
Weimin Feng, Qingchen Wang, Yuan Tan, et al.
Clinica Chimica Acta (2024) Vol. 565, pp. 120000-120000
Open Access | Times Cited: 2
Weimin Feng, Qingchen Wang, Yuan Tan, et al.
Clinica Chimica Acta (2024) Vol. 565, pp. 120000-120000
Open Access | Times Cited: 2
Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model
Michaela Adamcová, Helena Párová, Olga Lenčová-Popelová, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 1
Michaela Adamcová, Helena Párová, Olga Lenčová-Popelová, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 1
Transforming Cardiotoxicity Detection in Cancer Therapies: The Promise of MicroRNAs as Precision Biomarkers
Isabel Moscoso, Moisés Rodríguez‐Mañero, María Cebro-Márquez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11910-11910
Open Access | Times Cited: 1
Isabel Moscoso, Moisés Rodríguez‐Mañero, María Cebro-Márquez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11910-11910
Open Access | Times Cited: 1
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review
Roberto Rosenfeld, Silvia Riondino, Vincenzo Formica, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1059-1059
Open Access | Times Cited: 5
Roberto Rosenfeld, Silvia Riondino, Vincenzo Formica, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1059-1059
Open Access | Times Cited: 5
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Ziyu Kuang, Yuansha Ge, Luchang Cao, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1038-1054
Open Access
Ziyu Kuang, Yuansha Ge, Luchang Cao, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1038-1054
Open Access
